Telix Pharmaceuticals Ltd
TLX13.340USD
+0.290+2.22%
시장 운영 시간 （ET）시세는 15분 지연됩니다
0.00시가총액
--P/E TTM
자세한 내용은 Telix Pharmaceuticals Ltd 회사
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical devices. It develops a portfolio of clinical and commercial stage products that addresses significant unmet medical needs in oncology and rare diseases. It operates a pipeline of theranostic radiopharmaceutical product candidates with a focus on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning. Its segments include commercial, product development, medical technologies, and manufacturing services. Its lead imaging product is gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix). Its other pipelines include TLX591, TLX592, TLX250, TLX101, TLX300, TLX66, TLX66-CDx, and TLX090, among others.
회사 정보
종목 코드 TLX
회사 이름Telix Pharmaceuticals Ltd
상장일Nov 15, 2017
CEOMr. Kevin Richardson
직원 수- -
유형Ordinary Share
회계 연도 종료- -
주소55 Flemington Road
도시MELBOURNE
증권 거래소Xetra
국가Australia
우편 번호3051
전화61390933855
웹사이트https://telixpharma.com/
종목 코드 TLX
상장일Nov 15, 2017
CEOMr. Kevin Richardson
회사 임원
이름
이름/직위
직위
주식 보유
변동
Ms. Marie McDonald
Ms. Marie McDonald
Non-Executive Director
Non-Executive Director
--
--
Dr. Paul Schaffer
Dr. Paul Schaffer
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Richard Valeix
Mr. Richard Valeix
Group Chief Commercial Officer
Group Chief Commercial Officer
--
--
Mr. James Stonecypher
Mr. James Stonecypher
Group Chief Development Officer
Group Chief Development Officer
--
--
Dr. Mark Nelson, Ph.D.
Dr. Mark Nelson, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tiffany P. Olson
Ms. Tiffany P. Olson
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Christian P. Behrenbruch, J.D., Ph.D.
Dr. Christian P. Behrenbruch, J.D., Ph.D.
Group Chief Executive Officer, Managing Director, Executive Director
Group Chief Executive Officer, Managing Director, Executive Director
--
--
Mr. Darren Smith, CPA
Mr. Darren Smith, CPA
Group Chief Financial Officer
Group Chief Financial Officer
--
--
Ms. Genevieve Ryan
Ms. Genevieve Ryan
Company Secretary
Company Secretary
--
--
Dr. David Cade
Dr. David Cade
Group Chief Medical Officer
Group Chief Medical Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Marie McDonald
Ms. Marie McDonald
Non-Executive Director
Non-Executive Director
--
--
Dr. Paul Schaffer
Dr. Paul Schaffer
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Richard Valeix
Mr. Richard Valeix
Group Chief Commercial Officer
Group Chief Commercial Officer
--
--
Mr. James Stonecypher
Mr. James Stonecypher
Group Chief Development Officer
Group Chief Development Officer
--
--
Dr. Mark Nelson, Ph.D.
Dr. Mark Nelson, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tiffany P. Olson
Ms. Tiffany P. Olson
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: 15 hours ago
마지막 업데이트: 15 hours ago
주주
주주 유형
주주
주주
비율
Pier Capital, LLC
0.02%
Other
99.98%
주주
주주
비율
Pier Capital, LLC
0.02%
Other
99.98%
주주 유형
주주
비율
Investment Advisor
0.03%
Other
99.97%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
9
52.71K
0.02%
+48.98K
2025Q1
6
20.71K
0.01%
+16.98K
2024Q4
1
3.73K
0.00%
+3.73K
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Private Advisor Group LLC
10.14K
0%
+10.14K
--
Mar 31, 2025
UBS Financial Services, Inc.
3.65K
0%
-79.00
-2.12%
Mar 31, 2025
Morgan Stanley & Co. LLC
2.90K
0%
+2.90K
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
2.73K
0%
+2.73K
--
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
1.15K
0%
+1.15K
--
Mar 31, 2025
EverSource Wealth Advisors, LLC
137.00
0%
+137.00
--
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
